lectur beta-cel type II mellitu immunoassay insulin signific quantiti hormon non-insulin-depend type II yr debat beta-cel abnorm etiolog role syndrom earli effort adequaci islet beta-cel function obes associ insulin resist major variabl glucos insulin synthesi secret islet signal substrat hormon neural factor obes glucos account clear patient hyperglycemia abnorm islet function type II defect first-phas acut glucose-induc insulin secret defici abil glucos islet nonglucos beta-cel secretagogu hyperglycemia compens defect glucos potenti normal basal insulin level insulin respons secretagogu defect first-phas glucose-induc insulin releas develop hyperglycemia first-phas glucose-induc insulin secret defect progress islet failur glucos level basal second-phas insulin output relationship islet function plasma glucos steepli curvilinear loss beta-cel function time diagnost level mg/dl new steadi state glucos overproduct ineffici util insulin resist present patient contribut hyperglycemia glucos level compens decompens absolut hypoinsulinemia occur renal threshold glucos prevent elev glucos etiolog islet beta-cel lesion hypothesi basal hyperproinsulinemia islet amyloid deposit pancrea type II recent discoveri islet amyloid polypeptid iapp amylin major constitu islet amyloid deposit hypothesi pro-iapp proinsulin process matur peptid secret abnorm process secondari conjunct defect hormon secret lead progress accumul intracellular iapp pro-iapp cat monkey human intracellular fibril amyloid deposit loss beta-cel mass abstract truncat AT word 